中药加化疗治疗老年晚期非小细胞肺癌61例临床观察

目的 观察中药合并化疗治疗老年晚期非小细胞肺癌的临床疗效.方法 将61例老年晚期非小细胞肺癌患者随机分为两组.其中治疗组30例,口服中药汤剂加单药化疗;对照组31例,口服中药汤剂加联合化疗,两组均21 d为1个疗程,共治疗2个疗程.结果 治疗组在生活质量、症状、毒副反应、治疗费等方面均优于对照组,两组间比较有统计学意义(P<0.05).结论 中药加化疗治疗老年晚期非小细胞肺癌有效.

Clinical Study on Treatment of 61 Cases of Elderly Patients with Advanced Non-small Cell Lung Cancer with Chinese Medicine Combined Chemotherapy

Objective To observe clinical effect of Chinese medicine combined chemotherapy in the treatment of elderly patients with advanced non-small cell lung cancer. Methods 61 cases of elderly patients with advanced non-small cell lung cancer patients were randomly recruited into two groups. 30 cases in treatment group, which was treated with Chinese medicine combined single-drug chemotherapy, 31 cases in control group, which was treated with Chinese medicine combined combination-chemotherapy. After 42 days of 2 cycle, the clinical effect of both groups was observed. Results The treatment group was superior to the control group on improvement of quality of life, symptomatic improvement, the toxicity of chemotherapy and treatment costs. The difference between the two groups were significant (P< 0.05) . Conclusion Chinese medicine combined single-drug chemotherapy in the treatment of elderly patients with advanced non-small cell lung cancer is superior to combined combination-chemotherapy.